請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/88657
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 楊台鴻 | zh_TW |
dc.contributor.advisor | Tai-Horng Young | en |
dc.contributor.author | 邱昱勳 | zh_TW |
dc.contributor.author | Yu-Hsun Chiu | en |
dc.date.accessioned | 2023-08-15T17:14:58Z | - |
dc.date.available | 2023-11-09 | - |
dc.date.copyright | 2023-08-15 | - |
dc.date.issued | 2023 | - |
dc.date.submitted | 2023-08-08 | - |
dc.identifier.citation | Alkhraisat MH, Rueda C, Mariño FT, Torres J, Jerez LB, Gbureck U. (2009) The effect of hyaluronic acid on brushite cement cohesion. Acta Biomaterialia. 5:3150-6.
Barone AW, Andreana S, Dziak R. (2020) Current Use of Calcium Sulfate Bone Grafts. Medical Research Archives. 8. Barralet JE, Hofmann M, Grover LM, Gbureck UJAM. (2003) High‐strength apatitic cement by modification with α‐hydroxy acid salts. 15:2091-4. Berthiaume F, Maguire TJ and Yarmush ML. (2011) Tissue engineering and regenerative medicine: history, progress, and challenges. Annu Rev Chem Biomol Eng.2:403-430. Blouin S, Moreau MF, Weiss P, Daculsi G, Baslé MF, Chappard D. (2006) Evaluation of an injectable bone substitute (betaTCP/hydroxyapatite/hydroxy-propyl-methyl-cellulose) in severely osteopenic and aged rats. Journal of biomedical materials research Part A. 78:570-80. Borchard NA, Dholakia SS, Yan CH, Zarabanda D, Thamboo A, Nayak JV. (2019) Use of intranasal submucosal fillers as a transient implant to alter upper airway aerodynamics: implications for the assessment of empty nose syndrome. Int Forum Allergy Rhinol. 9:681-7. Boyle KK, Sosa B, Osagie L, Turajane K, Bostrom MPG, Yang X. (2019) Vancomycin-laden calcium phosphate-calcium sulfate composite allows bone formation in a rat infection model. PLoS One. 14:e0222034-e. Burguera EF, Xu HH, Weir MD. (2006) Injectable and rapid-setting calcium phosphate bone cement with dicalcium phosphate dihydrate. Journal of biomedical materials research Part B, Applied biomaterials. 77:126-34. Cai Z, Wu Z, Wan Y, Yu T, Zhou C. (2021) Manipulation of the degradation behavior of calcium phosphate and calcium sulfate bone cement system by the addition of micro-nano calcium phosphate. Ceramics International. 47:29213-24. Chen IC, Su CY, Lai CC, Tsou YS, Zheng Y, Fang HW. (2021) Preparation and Characterization of Moldable Demineralized Bone Matrix/Calcium Sulfate Composite Bone Graft Materials. Journal of functional biomaterials. 12. Chenite A, Chaput C, Wang D, Combes C, Buschmann MD, Hoemann CD, Leroux JC, Atkinson BL, Binette F, Selmani A. (2000) Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials. 21:2155-2161. Chen Z, Liu H, Liu X, Lian X, Guo Z, Jiang HJ. (2013) Improved workability of injectable calcium sulfate bone cement by regulation of self-setting properties. Materials science & engineering C, Materials for biological applications. 33:1048-53. Cherng A, Takagi S, Chow LC. (1997) Effects of hydroxypropyl methylcellulose and other gelling agents on the handling properties of calcium phosphate cement. Journal of biomedical materials research. 35:273-7. Chiang H-H, Su C-Y, Hsu L-H, Yang M-H, Fang H-W. (2021) Improved Anti-Washout Property of Calcium Sulfate/Tri-Calcium Phosphate Premixed Bone Substitute with Glycerin and Hydroxypropyl Methylcellulose. Applied Sciences. 11: 8136. Coetzee AS. (1980) Regeneration of bone in the presence of calcium sulfate. Archives of otolaryngology (Chicago, Ill : 1960). 106:405-9. Concaro S, Nicklasson E, Ellowsson L, Lindahl A, Brittberg M, Gatenholm P. (2008) Effect of cell seeding concentration on the quality of tissue engineered constructs loaded with adult human articular chondrocytes. J Tissue Eng Regen Med. 2:14-21. Deng A, Kang X, Zhang J, Yang Y and Yang S. (2017) Enhanced gelation of chitosan/β- sodium glycerophosphate thermosensitive hydrogel with sodium bicarbonate and biocompatibility evaluated. Materials Science and Engineering C. 78: 1147-1154. Evaniew N, Tan V, Parasu N, Jurriaans E, Finlay K, Deheshi B. (2013) Use of a calcium sulfate-calcium phosphate synthetic bone graft composite in the surgical management of primary bone tumors. Orthopedics. 36:e216-22. Fisher M, Alba B, Ahmad J, Robotti E, Cerkes N, Gruber RP, Rohrich RJ, Bradley JP Tanna N. (2022) Current Practices in Dorsal Augmentation Rhinoplasty. Plast Reconstr Surg. 149:1088-1102. Guan Q, Sui Y, Zhang F, Yu W, Bo Y, Wang P. (2021) Preparation of α-calcium sulfate hemihydrate from industrial by-product gypsum: a review. Physicochemical Problems of Mineral Processing. 57:168-81. Haugen HJ, Lyngstadaas SP, Rossi F, Perale G. (2019) Bone grafts. which is the ideal biomaterial? Journal of clinical periodontology. 46 Suppl 21:92-102. Hong HR, Jang YJ. (2016) Correlation between remnant inferior turbinate volume and symptom severity of empty nose syndrome. The Laryngoscope. 126:1290-5. Ishikawa K, Miyamoto Y, Kon M, Nagayama M, Asaoka K. (1995) Non-decay type fast-setting calcium phosphate cement: composite with sodium alginate. Biomaterials. 16:527-32. Jeong J, Kim JH, Shim JH, Hwang NS, Heo CY. (2019) Bioactive calcium phosphate materials and applications in bone regeneration. Biomaterials research. 23:4. Kafienah W, Jakob M, Demarteau O, Frazer A, Barker MD, Martin I, Hollander AP. (2002) Three-dimensional tissue engineering of hyaline cartilage: Comparison of adult nasal and articular chondrocytes. Tissue Eng. 8:817–826. Kanjanawasee D, Cambell RG, Rimmer J, Alvarado R, Kanjanaumporn J, Snidvongs K, Kalish L, Harvey RJ, Sacks R. (2021) Empty Nose Syndrome Pathophysiology: A Systematic Review. Otolaryngol Head Neck Surg. Oct 19. Online ahead of print. Khor E, Lim LY. (2003) Implantable applications of chitin and chitosan. Biomaterials. 24:2339–2349. Kim CH, Park SJ, Yang DH, Chun HJ. (2018) Chitosan for Tissue Engineering. Adv Exp Med Biol. 1077:475-485. Kuan EC, Suh JD, Wang MB. (2015) Empty Nose Syndrome. Curr Allergy Asthma Rep.15:493. Lahiji A, Sohrabi A, Hungerford DS, Frondoza CG. (2000) Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. J Biomed Mater Res. 51:586-95. Lamb M, Bacon DR, Zeatoun A, Onourah P, Thorp BD, Abramowitz J, Ebert CS Jr, Kimple AJ, Senior BA. (2022) Mental health burden of empty nose syndrome compared to chronic rhinosinusitis and chronic rhinitis. Int Forum Allergy Rhinol. Mar 25. Online ahead of print. Langer R, Vacanti JP. (1993) Tissue engineering. Science. 260:920–926. Laurencin C, Khan Y, El-Amin SF. (2006) Bone graft substitutes. Expert review of medical devices. 3:49-57. Lee TJ, Fu CH, Wu CL, Tam YY, Huang CC, Chang PH, Chen YW, Wu MH. (2016)Evaluation depression and anxiety in empty nose syndrome after surgical treatment. Laryngoscope. 126:1284–9. Leong SC. (2015) The clinical efficacy of surgical interventions for empty nose syndrome : A systematic review. The Laryngoscope. 125:1557-62. Lewis KN, Thomas MV, Puleo DA. (2006) Mechanical and degradation behavior of polymer-calcium sulfate composites. Journal of materials science Materials in medicine. 17:531-7. Li C, Farag AA, Maza G, McGhee S, Ciccone MA, Deshpande B, Pribitkin EA, Otto BA,Zhao K. (2018) Investigation of the abnormal nasal aerodynamics and trigeminal functions among empty nose syndrome patients. Int Forum Allergy Rhinol. 8:444-52. Liu H, Li H, Cheng W, Yang Y, Zhu M, Zhou C. (2006) Novel injectable calcium phosphate/chitosan composites for bone substitute materials. Acta Biomaterialia. 2:557-65. Liu W, Zhang J, Rethore G, Khairoun K, Pilet P, Tancret F. (2014) A novel injectable, cohesive and toughened Si-HPMC (silanized-hydroxypropyl methylcellulose) composite calcium phosphate cement for bone substitution. Acta Biomater. 10:3335-45. Liu W, Zhang J, Weiss P, Tancret F, Bouler J-M. (2013) The influence of different cellulose ethers on both the handling and mechanical properties of calcium phosphate cements for bone substitution. Acta Biomaterialia. 9:5740-50. Moseke C, Gbureck U. (2010) Tetracalcium phosphate: Synthesis, properties and biomedical applications. Acta Biomaterialia. 6:3815-23. Muzzarelli R, Baldassarre V, Conti F. (1988) Biological activity of chitosan: ultrastructural study. Biomaterials. 9:247-252. Oluwole M, Mills RP. (1994) An audit of the early complications of turbinectomy. Annals of the Royal College of Surgeons of England. 76:339-41. Passali D, Rosa RL, Passali GC, Ciprandi G. (2021) The Empty Nose Syndrome: a pragmatic classification in clinical practice. Acta Biomed. 92: e2021288. Pavicic T, Webb KL, Frank K, Gotkin RH, Tamura B, Cotofana S. (2019) Arterial wall penetration forces in needles versus cannulas. Plastic & Reconstructive Surgery. 143:504e-12e. Regan WB, Stacey TG. (2018) Surgical Management of Turbinate Hypertrophy. Otolaryngol Clin North Am. 51:919-28. Roberts TT, Rosenbaum AJ. (2012) Bone grafts, bone substitutes and orthobiologics. Organogenesis. 8:114-24. Sancho-Tello M, Martorell S, Mata RM, Milián L, Gámiz-González MA, Gómez Ribelles JL, Carda C. (2017) Human platelet-rich plasma improves the nesting and differentiation of human chondrocytes cultured in stabilized porous chitosan scaffolds. J Tissue Eng. 8:2041731417697545. Sarda S, Fernández E, Nilsson M, Balcells M, Planell JA. (2002) Kinetic study of citric acid influence on calcium phosphate bone cements as water-reducing agent. 61:653-9. Schlickewei CW, Laaff G, Andresen A, Klatte TO, Rueger JM, Ruesing J. (2015) Bone augmentation using a new injectable bone graft substitute by combining calcium phosphate and bisphosphonate as composite—an animal model. Journal of Orthopaedic Surgery and Research. 10:116. Smirnov VV, Antonova OS, Goldberg MA, Smirnov SV, Shvorneva LI, Egorov AA. (2016) Bone cements in the calcium phosphate–calcium sulfate system. Doklady Chemistry. 467:136-9. Suh MK. (2021) Cosmetic Augmentation Rhinoplasty for East Asians. Facial Plast Surg Clin North Am. 29:589-609. Tan NC, Goggin R, Psaltis AJ, Wormald PJ. (2018) Partial resection of the middle turbinate during endoscopic sinus surgery for chronic rhinosinusitis does not lead to an increased risk of empty nose syndrome: a cohort study of a tertiary practice. Int Forum Allergy Rhinol. Apr 6. Online ahead of print. Tay AG, Farhadi J, Suetterlin R, Pierer G, Heberer M, Martin I. (2004) Cell yield, proliferation, and postexpansion differentiation capacity of human ear, nasal, and rib chondrocytes. Tissue Eng. 10:762–770. Temenoff JS, Mikos AG. (2000) Review: tissue engineering for regeneration of articular cartilage. Biomaterials. 21: 431–440. Thai VV, Lee BT. (2010) Fabrication of calcium phosphate-calcium sulfate injectable bone substitute using hydroxy-propyl-methyl-cellulose and citric acid. Journal of materials science Materials in medicine. 21:1867-74. Thomas MV, Puleo DA. (2009) Calcium sulfate: Properties and clinical applications. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 88B:597-610. Wang X, Chen L, Xiang H, Ye J. (2007) Influence of anti-washout agents on the rheological properties and injectability of a calcium phosphate cement. Journal of Biomedical Materials Research Part B: Applied Biomaterials.81B:410-8. Wang Y-W, Meldrum FC. (2012) Additives stabilize calcium sulfate hemihydrate (bassanite) in solution. Journal of Materials Chemistry. 22:22055-62. Wiggenhauser PS, Schantz JT, Rotter N. (2017) Cartilage engineering in reconstructive surgery: auricular, nasal and tracheal engineering from a surgical perspective. Regen Med. 12:303-314. Xu Y, Fan F, Kang N, Wang S, You J, Wang H, Zhang B. (2015) Tissue engineering of human nasal alar cartilage precisely by using three-dimensional printing. Plast Reconstr Surg. 135:451-458. Yang TL. (2011)Chitin-based Materials in Tissue Engineering: Applications in Soft Tissue and Epithelial Organ. Int. J. Mol. Sci. 12:1936-1963. Zhang L, Guan X, Xiao X, Chai Y, Chen Z, Zhou G, Fan Y. (2022) Near-infrared triggered injectable ferrimagnetic chitosan thermosensitive hydrogel for photo hyperthermia and precisely controlled drug release in tumor ablation. EuropeanPolymer Journal. 162:110879. Zhang J, Liu W, Schnitzler V, Tancret F, Bouler JM. (2014) Calcium phosphate cements for bone substitution: chemistry, handling and mechanical properties. Acta Biomater. 10:1035-49. Zhou HY, Chen XG, Kong M, Liu CS, Cha DS, Kennedy JF. (2008) Effect of molecular weight and degree of chitosan deacetylation on the preparation and characteristics of chitosan thermosensitive hydrogel as a delivery system. Carbohydrate Polymers. 73: 265–273. | - |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/88657 | - |
dc.description.abstract | 自體軟骨不足是當前鼻顏面重建領域的一個重大挑戰,尤其在治療空鼻症和進行再次鼻整形手術時。
空鼻症是鼻甲手術後的一種少見但嚴重的併發症,其臨床症狀包括矛盾性鼻阻塞、鼻部乾燥感和呼吸困難。遺憾的是,目前尚無ㄧ致公認有效的空鼻症治療方法。目前的治療策略包括藥物治療,如鼻部潤滑劑、局部抗生素和皮質類固醇的使用,以及外科手術。然而,這些治療方法的缺點和局限性包括外科手術的困難度高、植入物感染的風險以及手術成效不明確。因此我們需要進一步研究,以開發有效和侵入性低的治療方式來改善空鼻症患者的症狀。為了克服現有治療的局限性,我們的第一個研究的目標是開發新型的可注射生物材料植入物,用於微創手術的方法來治療空鼻症。 我們製備了一種可注射的複合骨移植物,其中含有半水硫酸鈣、四鈣磷酸鹽和無水磷酸氫鈣(CSH/CaP糊劑),並調整了不同的CSH/CaP比例和添加劑的濃度。且對該注射複合骨糊劑的固化時間、可注射性、力學性能和生物相容性進行了評估。 經過研究,我們開發的可注射CSH/CaP糊劑(CSH/CaP比例為1:1,補充了6%檸檬酸和2%羥丙甲纖維素)具有良好的操控性能,很好的生物相容性和適當的機械強度。此外,該糊劑可以從裝有18G針頭的針筒中擠出,展現了可運用在微創手術中的巨大潛力。該開發的可注射植入物具有修復組織的潛力,將為治療空鼻症和鼻顏面重建提供理想的微創手術治療策略。 二次鼻整形手術被認為是整形外科領域中最具挑戰性的手術之一。我們第二個研究的目的是評估幾丁聚醣對鼻中隔軟骨細胞(NSCs)生長的影響。最終目標是建立一種新的方法來增強鼻中隔軟骨的再生。我們成功地從人體鼻中隔軟骨中分離出鼻中隔軟骨細胞,並使用阿爾西藍染色,在光學顯微鏡下觀察鼻中隔軟骨細胞的形態。我們以不同濃度的幾丁聚醣培養分離出來的鼻中隔軟骨細胞,並研究二型膠原蛋白基因(COL2A1)的表現。 我們的研究結果顯示,可從人體鼻中隔軟骨中成功地分離出鼻中隔軟骨細胞。與對照組細胞相比,與0.2%的幾丁聚醣共培養明顯增強了鼻中隔軟骨細胞的增殖。然而,0.5%的幾丁聚醣對鼻中隔軟骨細胞有害,導致細胞從培養皿上脫落。此外,添加0.2%的幾丁聚醣顯著提高了鼻中隔軟骨細胞中二型膠原蛋白基因的表現。 根據我們的了解,這是首次研究發表幾丁聚醣能有效地引導人類鼻中隔軟骨細胞的附著和生長。幾丁聚醣應是一種值得發展的人類鼻中隔軟骨細胞培養添加劑,為研究鼻中隔軟骨缺失和鼻顏面重建的組織再生奠定了基礎。 | zh_TW |
dc.description.abstract | The insufficient cartilage is a significant obstacle within the present domain of nasofacial reconstruction, especially when treating empty nose syndrome and performing secondary rhinoplasty.
Empty nose syndrome (ENS) is an infrequent occurrence following turbinate surgery, characterized by clinical symptoms such as paradoxical nasal obstruction, nasal dryness, and feeling of dyspnea. Unfortunately, there are no effective treatments for ENS up to date. Current management strategies include medical therapies such as nasal lubricants, local antibiotics and corticosteroids application, and surgical techniques. However, the surgical difficulties, risk of infection from implantation and ambiguous results of surgery are the disadvantages and limitations of these treatments. Therefore, to develop effective and low invasive treatments for improving ENS patient’s symptoms is necessary and requires further investigation. To overcome the existing treatment limitations, the aim of our first study is to develop novel injectable implants from biomaterials for minimally invasive surgery to treat ENS. An injectable composite bone graft containing calcium sulfate hemihydrate, tetracalcium phosphate and anhydrous calcium hydrogen phosphate (CSH/CaP paste) was prepared with different CSH/CaP ratios and different concentration of additives. Setting time, injectability, mechanical properties, and biocompatibility were evaluated. The developed injectable CSH/CaP paste (CSH/CaP 1:1 supplemented with 6% citric acid and 2% HPMC) presented good handling properties, great biocompatibility and adequate mechanical strength. Furthermore, the paste was demonstrated to be extruded from syringe equipped with 18G needles and exerted great potential for minimally invasive surgery. The developed injectable implants with tissue repairing potentials will provide an ideal therapeutic strategy for minimally invasive surgery to treat ENS and apply in nasofacial reconstruction. Within the realm of plastic surgery, performing secondary rhinoplasty is widely acknowledged as one of the most demanding procedures. Our secondary study aimed to assess the impact of chitosan on the growth of nasal septal chondrocytes (NSCs). The ultimate objective was to establish an innovative methodology to enhance nasal septal cartilage regeneration. Human NSCs were isolated and the morphology of NSCs was examined by Alcian blue staining and observed by light microscopy. The isolated NSCs were grown with various concentrations of chitosan and the expression of COL2A1 was investigated. NSCs were found to be successfully isolated from nasal septal cartilage. Treated with 0.2 % of chitosan greatly enhanced proliferation of NSCs compared to control cells. However, 0.5 % of chitosan was harmful to NSCs, resulting in cell detachment from the culture plate. Moreover, the inclusion of 0.2% chitosan notably enhanced the expression of COL2A1 in NSCs. To the best of our knowledge, this is the initial documentation showcasing the effectiveness of chitosan in facilitating the attachment and proliferation of human NSCs. Chitosan appears to be a promising additive for NSC culture, which lays the foundation for investigating tissue regeneration in the context of nasal septal cartilage deficiency and nasofacial reconstruction. | en |
dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2023-08-15T17:14:58Z No. of bitstreams: 0 | en |
dc.description.provenance | Made available in DSpace on 2023-08-15T17:14:58Z (GMT). No. of bitstreams: 0 | en |
dc.description.tableofcontents | 口試委員會審定書 i
中文摘要 ii 英文摘要 iv 縮寫表 vi Chapter 1: Background and Introduction 1 Chapter 2: Development of Injectable Calcium Sulfate and Self-Setting Calcium Phosphate Composite Bone Graft Materials in the treatment of empty nose syndrome 2.1 Materials and Methods 6 2.1.1. Calcium Sulfate Hemihydrate (CSH) Preparation 6 2.1.2. Scanning Electron Microscope (SEM) 6 2.1.3. Fourier Transform Infrared Spectroscopy (FTIR) 6 2.1.4. X-rayDiffraction…(XRD) 6 2.1.5. CSH/CaP composite bone graft formulation and paste preparation 7 2.1.6. Setting time measurement 7 2.1.7. Injectability 7 2.1.8. Mechanical Compression Testing 8 2.1.9. Degradation Test and pH value measurement 8 2.1.10. Cell Viability 8 2.1.11. Statistics 9 2.2. Results 10 2.2.1. The synthesis of calcium sulfate hemihydrate (CSH, CaSO4·0.5H2O) 10 2.2.2. Altering the handling property of CSH/CaP composite bone materials by citric acid 10 2.2.3. Effects of CSH/CaP ratio on mechanical properties 11 2.2.4. Effects of hydroxyl propyl methyl cellulose (HPMC) on the properties CSH/CaP composite bone graft materials 12 2.2.5. Biocompatibility of CSH/CaP paste 13 2.3. Discussion 14 Chapter 3: Effects of chitosan on chondrocytes derived from human nasal septal cartilage 3.1. Materials and Methods 29 3.1.1. Isolation of primary human NSCs 29 3.1.2. Alcian blue staining of primary chondrocytes 29 3.1.3. Primary human chondrocytes treated with chitosan solution 30 3.1.4. Gene expression analysis 30 3.1.5. Statistical analysis 30 3.2. Results 32 3.2.1. Isolation of primary human NSCs 32 3.2.2. Effects of chitosan on growth of primary human NSCs 32 3.2.3. Effects of chitosan on gene expression of primary human NSCs 32 3.3. Discussion 34 Chapter 4: Conclusion and future prospects 39 Chapter 5: References 41 Chapter 6: List of publications 49 圖表目錄 Chapter 2 Figure 1 Characterization of synthesized CSH 17 Figure 2 Injectability tests of CSH/CaP (1:3) bone graft materials by 18G syringe injection 18 Figure 3 Injectability tests of CSH/CaP (1:1) bone graft materials by 18G syringe injection 19 Figure 4 Properties of CSH/CaP (1:3 white bars; 1:1 black bars) composite graft materials 20 Figure 5 Injectability tests of CSH/CaP bone graft materials by 18G syringe injection 21 Figure 6 Properties of CSH/CaP composite graft materials without or with 2% HPMC 22 Figure 7 Properties of CSH/CaP pastes without or with 2% HPMC 23 Figure 8 XRD profiles of CSH/CaP paste (CSH/CaP 1:1, 6% citric acid, 2% HPMC) immersed in PBS for 1, 2 and 12 weeks 24 Figure 9 Cell viability of L929 cells measured by MTT assay for evaluating the biocompatibility of CSH/CaP paste 25 Table 1 Chemical compositions and handling properties of CSH/CaP (1:3) bone graft 26 Table 2 Chemical compositions and handling properties of CSH/CaP (1:1) bone graft materials 27 Table 3 Chemical compositions and handling properties of CSH/CaP (1:1) bone graft materials 28 Chapter 3 Figure 1 Morphology of primary human NSCs 36 Figure 2 NSCs were treated with chitosan solution, and cell proliferation was evaluated on day 3 37 Figure 3 The impact of chitosan on the gene expression of primary human NSCs 38 | - |
dc.language.iso | en | - |
dc.title | 生醫材料於鼻顏面重建組織工程之應用 | zh_TW |
dc.title | The applications of biomaterials in tissue engineering of nasofacial reconstruction | en |
dc.type | Thesis | - |
dc.date.schoolyear | 111-2 | - |
dc.description.degree | 博士 | - |
dc.contributor.oralexamcommittee | 婁培人;侯勝博;李亦宸;洪智煌;胡威文 | zh_TW |
dc.contributor.oralexamcommittee | Pei-Jen Lou;Sheng-Po Hao;Yi-Chen Li;Chih-Huang Hung ;Wei-Wen Hu | en |
dc.subject.keyword | 空鼻症,可注射性,半水硫酸鈣,磷酸鈣,人類鼻中隔軟骨細胞,幾丁聚醣,軟骨組織工程, | zh_TW |
dc.subject.keyword | Empty nose syndrome (ENS),Injectable,Calcium sulfate hemihydrate,Calcium phosphate,Nasal septal chondrocytes (NSCs),Chitosan,Cartilage tissue engineering, | en |
dc.relation.page | 49 | - |
dc.identifier.doi | 10.6342/NTU202302951 | - |
dc.rights.note | 同意授權(限校園內公開) | - |
dc.date.accepted | 2023-08-08 | - |
dc.contributor.author-college | 工學院 | - |
dc.contributor.author-dept | 醫學工程學系 | - |
顯示於系所單位: | 醫學工程學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-111-2.pdf 授權僅限NTU校內IP使用(校園外請利用VPN校外連線服務) | 6.64 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。